Anti-ischemic effect

The "anti-ischemic effect" is a clinical and pharmacological term used to describe any action or drug property that ameliorates damage caused by ischemia, such as myocardial infarction (heart attack) or ischemic stroke. Mechanistically, anti-ischemic effects may result from modulation of metabolic, ionic, or signaling pathways—for example, by improving energetics, blocking cell death signals, inhibiting inflammation, or restoring blood flow[2][3][5][6][7][8]. However, this term does **not correspond to a single, specific protein, receptor, or molecular target**, and is thus **inappropriate for use as a structured target entry**. Specific anti-ischemic effects are produced by drugs acting on discrete targets (e.g., adenosine receptors, sodium channels, tissue plasminogen activator, cytokine pathways), with research continuing to expand the spectrum of molecular interventions offering anti-ischemic benefits[2][3][5][6][7][8].